Baxter International Inc

Temple-Inland Inc. Q2 2008 Earnings Call Transcript

Seeking Alpha (Free subscription) | 08/05/2008

Baxter International Inc. (TIN) Q2 2008 Earnings Call Complete Story »

Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year

PR News Wire (Free subscription) | 09/05/2008

Company Named 2008 Medical Products Industry Leader DEERFIELD, Ill., Sept. 5 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: ) announced today that it has been named 2008 Medical Products Industry Leader of the Dow Jones Sustainability World Index (DJSI World) and the Dow Jones Sustainability North America Index (DJSI North America). This marks the tenth consecutive year...

Baxter boosted by drug's head start

Chicago Tribune (Free subscription) | 07/31/2008

Alzheimer's candidate used for other diseases As the pharmaceutical industry enters a critical phase before possible U.S. approval of a new Alzheimer's disease treatment, Deerfield-based Baxter International Inc. is among the firms with a drug showing promise to combat the disorder.

Drug Companies Study Immune-Based Therapies to Combat Alzheimer's

Red Orbit (Free subscription) | 07/31/2008

CHICAGO _ As the pharmaceutical industry enters a critical phase before possible U.S. approval for an Alzheimer's treatment, Baxter International Inc. is among the firms with a drug showing promise to combat the disease.

Baxter drug shows promise for Alzheimer's

Chicago Tribune (Free subscription) | 07/30/2008

A Baxter International Inc. drug used to treat immune system disorders shows promise as a treatment for Alzheimer's disease in a small-scale study the company has figured in its decision to now move to a critical, larger final stage.

Baxter Alzheimer’s drug effective at 9 months: study (Reuters)

Ph articles (Free subscription) | 07/30/2008

CHICAGO (Reuters) - Alzheimer's disease patients treated with Baxter International Inc's Gammagard for nine months maintained cognitive function and in some cases improved it, according to an interim analysis of data from a small study. "If successful, it should actually transmute the long-term course of the illness, and the effects should be steadfast for a very slow proper time," Dr. Norman...

Baxter Alzheimer's drug effective at 9 months: study

Reuters (Free subscription) | 07/30/2008

CHICAGO (Reuters) - Alzheimer's disease patients treated with Baxter International Inc's Gammagard for nine months maintained cognitive function and in some cases improved it, according to an interim analysis of data from a small study.

Promising new therapy for Alzheimer’s

Medical,Health News and Articles (Free subscription) | 07/31/2008

... of Neuropsychology in the Department of Neurology & Neuroscience at Weill Cornell Medical College. Baxter International Inc. supported the study and provided GAMMAGARD Liquid and GAMMAGARD S/D for the trial. GAMMAGARD contains a broad spectrum of immunoglobulins (antibodies), and is indicated as an immunoglobulin replacement therapy in patients with primary immunodeficiency disorders....

• Results of 9-Month Phase II Study of GAMMAGARD Intravenous Immunoglobulin (IGIV) in Patients with Alzheimer's Disease - Newswise
• Results of 9-month phase II study of gammagard intravenous immunoglobulin - Eurekalert

Results of 9-Month Phase II Study of GAMMAGARD Intravenous Immunoglobulin (IGIV) in Patients with Alzheimer's Disease

Newswise (Free subscription) | 07/31/2008

... of Neuropsychology in the Department of Neurology & Neuroscience at Weill Cornell Medical College.Baxter International Inc. supported the study and provided GAMMAGARD Liquid and GAMMAGARD S/D for the trial. GAMMAGARD contains a broad spectrum of immunoglobulins (antibodies), and is indicated as an immunoglobulin replacement therapy in patients with primary immunodeficiency disorders.In...

Deaths Linked To Heparin Batch

Health - The Post Chronicle (Free subscription) | 07/30/2008

A spike in the number of allergic reactions by hospital patients injected with the drug prompted its manufacturer, Baxter International Inc., of suburban Chicago, to pull the heparin from distribution in February. Since then, the U.S. Food and Drug Administration has been examining reports of 93 deaths related to heparin.

Deaths Linked To Contaminated Heparin Batch

Red Orbit (Free subscription) | 07/30/2008

A spike in the number of allergic reactions by hospital patients injected with the drug prompted its manufacturer, Baxter International Inc., of suburban Chicago, to pull the heparin from distribution in February. Since then, the U.S. Food and Drug Administration has been examining reports of 93 deaths related to heparin.

• Deaths Linked To Heparin Batch - Health - The Post Chronicle

News Release (HQ): EPA Climate Leaders Now 200 Partners Strong, Eight Companies Establish New Greenhouse Gas Reduction Goals

Auto Channel (Free subscription) | 07/24/2008

The eight companies that are announcing aggressive new greenhouse gas emissions reductions goals are: Baxter International Inc., Deerfield, Ill.; Burt's Bees Inc., Durham, N.C.; Campbell Soup Co., Camden, N.J.; Cherokee Investment Partners, Raleigh, N.C.; Cisco Systems Inc., San Jose, Calif.; Deere & Co., Moline, Ill.; Millipore Corp., Billerica, Mass.; and Petaluma Poultry,...

EPA Climate Leaders Now 200 Partners Strong, Eight Companies Establish New Greenhouse Gas Reduction Goals

Environmental Protection Agency (Free subscription) | 07/24/2008

... eight companies that are announcing aggressive new greenhouse gas emissions reductions goals are: Baxter International Inc., Deerfield, Ill.; Burt's Bees Inc., Durham, N.C.; Campbell Soup Co., Camden, N.J.; Cherokee Investment Partners, Raleigh, N.C.; Cisco Systems Inc., San Jose, Calif.; Deere & Co., Moline, Ill.; Millipore Corp., Billerica, Mass.; and Petaluma Poultry,...

Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results

News & Information (Free subscription) | 07/17/2008

Company Posts Second Quarter EPS of $0.85 Per Diluted Share, An Increase of 31 Percent DEERFIELD, Ill., July 17 /PRNewswire-FirstCall/ — Baxter International Inc…….Read more